A Safety Study of SGN-CD33A in Combination With Standard-of-care in Patients With AML
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Eric Feldman, MD
Seagen Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- City of Hope National Medical Center
Duarte, California, United States
- Colorado Blood Cancer Institute
Denver, Colorado, United States
- Cardinal Bernardin Cancer Center / Loyola University Medical Center
Maywood, Illinois, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Karmanos Cancer Institute / Wayne State University
Detroit, Michigan, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- Cleveland Clinic, the
Cleveland, Ohio, United States
- James Cancer Hospital / Ohio State University
Columbus, Ohio, United States
- Sarah Cannon Research Institute
Nashville, Tennessee, United States
- Charles A. Sammons Cancer Center / Baylor University Medical Center
Dallas, Texas, United States
- Md Anderson Cancer Center / University of Texas
Houston, Texas, United States
- Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2014
- Primary completion
- 30 Jan 2017
- Completion
- 10 Apr 2018
- Last update posted
- 9 May 2018
- Registered enrollment
- 116
- Registry id
- NCT02326584
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.